StockData

SANUWAVE Health vs TriSalus Life Sciences

SNWV and TLSI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SNWV and TLSI compare

TriSalus Life Sciences is the larger company, worth 9.7 times as much as SANUWAVE Health ($141M against $14.6M).

TriSalus Life Sciences grew revenue faster over the last twelve months (25.2% versus 12.7% for SANUWAVE Health).

SANUWAVE Health keeps more of each dollar of sales as profit, with a net margin of 34.7% compared with −62.6% at TriSalus Life Sciences.

SANUWAVE Health scores higher on the StockData Score (10 against 5 for TriSalus Life Sciences), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSNWVTLSI
Size and price
Market cap$14.6M$141M
Share price$1.70$2.29
Change, 1 year−94.8%−49.7%
Change, 5 years1208%−77.0%
Beta (5Y)3.182.29
Employees55102
StockData Score
Total score10 (better)5
Valuation score1 (better)0
Growth score23 (better)
Performance score2 (better)1
Health score5 (better)1
Dividend score00
Valuation
P/S0.3× (better)3.1×
P/B5.2× (better)21.6×
EV/EBITDA2.0×–
P/FCF3.4×–
FCF yield29.0% (better)−16.5%
Growth
Revenue growth (TTM)12.7%25.2% (better)
Revenue growth, 5Y average61.1%–
Profitability
Gross margin76.3%85.8% (better)
Operating margin3.4% (better)−67.7%
Net margin34.7% (better)−62.6%
FCF margin9.6% (better)−51.6%
Financial health
Debt / equity0.005.05 (better)
Interest coverage–−5.2×
Current ratio1.285.35 (better)
Altman Z-score−7.60−6.02 (better)
Piotroski F-score6 (better)3
Dividends and buybacks
Buyback yield–−31.3%
Shareholder yield0.00% (better)−31.3%
Ownership
Held by institutions37.3%38.6%
Held by insiders–29.7%
Insider net buying, 12 months−$11.6M$3.6M (better)

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.